- Laboratory >
- Laboratory medicine >
- Tumor marker reagent >
- FUJIREBIO
FUJIREBIO tumor marker reagents
{{product.productLabel}} {{product.model}}
{{#if product.featureValues}}{{product.productPrice.formattedPrice}} {{#if product.productPrice.priceType === "PRICE_RANGE" }} - {{product.productPrice.formattedPriceMax}} {{/if}}
{{#each product.specData:i}}
{{name}}: {{value}}
{{#i!=(product.specData.length-1)}}
{{/end}}
{{/each}}
{{{product.idpText}}}
{{product.productLabel}} {{product.model}}
{{#if product.featureValues}}{{product.productPrice.formattedPrice}} {{#if product.productPrice.priceType === "PRICE_RANGE" }} - {{product.productPrice.formattedPriceMax}} {{/if}}
{{#each product.specData:i}}
{{name}}: {{value}}
{{#i!=(product.specData.length-1)}}
{{/end}}
{{/each}}
{{{product.idpText}}}
... Laboratories can utilize the Fujirebio Diagnostics Tumor Marker Control as an independent internal quality control to monitor the performance of their tumor marker testing. The only ...
Fujirebio
... now widely used for detection and management of patients with prostatic cancer and considered as the superior serological marker for cancer of the prostate3. PSA has been shown to form stable complexes with different antiproteases ...
Fujirebio
... determination of AFP in serum may be valuable in the management of patients with suspected or diagnosed liver cancer or germ cell tumors of the testis or ovary ...
Fujirebio
... The CA125 monoclonal antibodies recognize epitopes in the protein core of the CA125 antigen. These monoclonal antibodies show high specificity for ovarian cancer, and can be used for development of fast and sensitive homologous or heterologous assays. According ...
Fujirebio
... PDTRPAPG region of the protein core2-5.The MUC 1 breast cancer mucin (CA15-3 antigen) is secreted from tumor cells and is a well-established serological marker for monitoring the clinical course of breast cancer patients ...
Fujirebio
... The CanAg CA19-9 EIA is based on a mouse monoclonal antibody, C192, highly specific for the sialyl Lewisa epitope, also known as CA19-9 antigen1. In adults, the epitope is typically expressed in trace amounts on mucosal cells of gastrointestinal epithelia. ...
Fujirebio
... The tumor marker CA242™ is defined by the monoclonal antibody C242™. The chemical structure of the antigenic determinant is not exactly known, but the determinant has been shown to be a sialylated carbohydrate structure. ...
Fujirebio
... on two mouse monoclonal antibodies against the Gold epitopes IV and V3, 4. CEA is secreted from tumor cells and is a widely used serological marker of gastrointestinal carcinomas, lung cancer, and breast cancer. In ...
Fujirebio
... now widely used for detection and management of patients with prostatic cancer and considered as the superior serological marker for cancer of the prostate3. PSA has been shown to form stable complexes with different antiproteases ...
Fujirebio
... The HE4 EIA is an enzyme immunometric assay for the quantitative determination of HE4 in human serum. The assay is to be used as an aid in monitoring response to therapy for patients with invasive epithelial ovarian cancer. The HE4 EIA is a solid-phase, ...
Fujirebio
Subscribe to our newsletter
Receive monthly updates on this section.
Please refer to our Privacy Policy for details on how MedicalExpo processes your personal data.
- Brand list
- Manufacturer account
- Buyer account
- Our services
- Newsletter subscription
- About VirtualExpo Group